Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer

A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

NCT03373955 ·Status: UNKNOWN

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

NCT03073902 ·Status: COMPLETED

Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

NCT07057102 ·Status: RECRUITING

NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

NCT04636047 ·Status: UNKNOWN

Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy

NCT06954259 ·Status: ACTIVE_NOT_RECRUITING

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Head and Neck Cancer

NCT05969262 ·Status: UNKNOWN

Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients

NCT02113852 ·Status: COMPLETED

Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion

NCT04263688 ·Status: UNKNOWN

A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

NCT06503042 ·Status: NOT_YET_RECRUITING

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

NCT05023746 ·Status: COMPLETED

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

NCT06699979 ·Status: RECRUITING

Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

NCT06907160 ·Status: RECRUITING

Biomarkers for Diagnosis of Lung Cancer

NCT02050100 ·Status: COMPLETED

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

NCT05637580 ·Status: COMPLETED

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

NCT04203095 ·Status: UNKNOWN

Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer

NCT06926179 ·Status: RECRUITING

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

NCT06613308 ·Status: NOT_YET_RECRUITING

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

NCT06843707 ·Status: RECRUITING

Gut Microbiota and Cancer Immunotherapy Response

NCT04682327 ·Status: UNKNOWN

Neoadjuvant Immunochemotherapy for Lung Cancer

NCT06023797 ·Status: COMPLETED

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

NCT06974097 ·Status: NOT_YET_RECRUITING

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390 ·Status: COMPLETED

Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer

NCT05260606 ·Status: RECRUITING

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

NCT05584267 ·Status: RECRUITING ·Phase: PHASE2